All News

Genomic testing has transformed the therapeutic landscape of lung cancer in recent years, but there is still room for improvement, says one expert.

A breast cancer survivor who had a double mastectomy with reconstruction talks about her nipple coloring process.

In a talk about her new book, Vanessa Bayer explains how leukemia contributed to her comic perspective and sense of empathy.

Having hope in the now is really faith in the future.

Here are the top 5 CURE stories for May 2019.

My tips and experience as a new acupuncture patient follow as a potential guide to getting beyond any fear of the procedure and potentially understanding the benefits of multiple sessions.

A male breast cancer survivor shares a note of gratitude to his surgeon.

Recently, I had my first experience with CBD oil and wrote a post about it on my blog. That was almost two months ago. Since that time, I’ve learned a lot more about using cannabidiol and the benefits associated with use. In this post, I’ll expound on the things I’ve learned through firsthand experience.

From today’s top performers to the latest in scientific research, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration granted a priority review to Darzalex in combination with Velcade (bortezomib), thalidomide and dexamethasone, also known as Vtd, for the front-line treatment of newly diagnosed patients with multiple myeloma.

Patients with chronic lymphocytic leukemia have newer options that include targeted therapy combinations and CAR-T cell therapy.

The Aplastic Anemia and MDS International Foundation records educational webinars for patients.

On June 19, the webinar to be presented is “Shared Decision Making - Empowering Patients,” taught by Susan Berg, MS, LGC, from the Center for Shared Decision Making at Dartmouth – Hitchcock.

Cancer can both open and close doors. It can make life feel crowded and foreign. It can bring out both the best and the worst in people, much like being on a crowded elevator can. As it creates space in our life it can also push us out of our comfort zones but it doesn't change who we are.

After I lost my real breasts, I gave up hope of ever having a "nice" body again.

Remembering to remain present through cancer.

In an interview with PEOPLE, "Jeopardy!" Host Alex Trebek reported he is in “near remission” from his stage 4 pancreatic cancer diagnosis.

After treatment, this survivor was terrified of everyone and everything until her very wise doctor said, “I did not put you through all this for you to put yourself in a bubble – go live your life.” And she has… for 16 years and counting.

Following surgery with medication, combining immunotherapies or targeted drugs and adding radiation to immunotherapy can improve effectiveness in treating various stages of melanoma.

Is this relative of the coffee plant a safer alternative to opioids or a dangerous, unregulated drug?

Despite scant research regarding medical use of cannabis, strong popular sentiment is driving legalization of the flowering plant for therapeutic use.

The Food and Drug Administration has approved the combination regimen of Revlimid plus Rituxan for use in patients with previously-treated follicular lymphoma and marginal zone lymphoma.

On those dark days, cancer survivors need to remember there are rays of sunshine behind the clouds.

As a cancer survivor and advocate, I have gotten the calls that we survivors hate: calls from someone we don’t know who says that a mutual friend told them to call, and friends saying they have been received a diagnosis. I am always ready when the phone rings.

We have to find light in the darkness of cancer not just for ourselves, but for those that will come after us.

Exercises specifically designed for breast cancer survivors are helpful after surgery and years out, if we remember to do them!

The Food and Drug Administration has approved the PI3K inhibitor Piqray (alpelisib) for the treatment of postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen.

The FDA has approved Jakafi, the first and only treatment of steroid-refractory acute graft-versus-host disease in adult and pediatric patients aged 12 years and older.

From World Blood Cancer Day to today’s top performers fundraising for lifesaving research, here’s what’s making headlines in the cancer space this week.

With greater longevity for survivors of melanoma comes the need to treat lingering side effects and monitor for cancer recurrences.